2024

1. Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment

   Infectious Diseases, Vol. 56, Núm. 7, pp. 575-580